The impact of demographic and clinical characteristics on diabetic painful neuropathy

被引:3
作者
Assuncao, Antonio [1 ]
Campos, Dina [1 ]
Marques, Rui [2 ]
Cunha, Ines [2 ]
Santos, Patricia [3 ]
Martins, Adriana [1 ]
Goncalves, Ana Sofia [4 ]
Rebelo, Ana [5 ]
Lima, Carolina [6 ]
Matos, Cesar [7 ]
Prata, Ana Cristina [3 ]
Teixeira, Jose Tiago [1 ]
Duarte, Luis [8 ]
Belo, Mariana [1 ]
Figueiredo, Patricia [3 ]
Rosa, Tiago Letras [9 ]
机构
[1] Family Hlth Unit FHU Viriato, Viseu, Portugal
[2] Tondela Viseu Hosp Ctr, Dept Internal Med, Viseu, Portugal
[3] FHU Sobreda, Almada Seixal, Portugal
[4] FHU Tondela, Tondela, Portugal
[5] FHU Cidade Jardim, Viseu, Portugal
[6] FHU S Pedro do Sul, Viseu, Portugal
[7] FHU Azeitao, Azeitao, Portugal
[8] FHU Grao Vasco, Viseu, Portugal
[9] FHU Vale Sorraia, Coruche, Portugal
关键词
diabetic neuropathy; neuralgia; diabetes mellitus; prevalence; diabetes complications; PERIPHERAL NEUROPATHY; GLUCOSE-TOLERANCE; STATEMENT;
D O I
10.2478/rjim-2019-0019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction. Diabetic neuropathy (DN) is one of the most devastating complications of diabetes mellitus; however, in contrast to other countries, there are no scientific studies in Portugal evaluating the impact of demographic and clinical characteristics of this pathological entity. The aim of this study was to evaluate the impact of gender, metabolic control, age of diabetic patients, as well as time of disease progression, the appearance of complaints related to neuropathic pain. Material and methods. A multicentre study with a non-probabilistic, convenience sample of 359 patients was performed employing the quantitative method, using the Statistical Package for Social Science 24 software. The p-value of p < 0.05 was defined to consider a result statistically significant. The Spearman correlation coefficient (r) was determined to determine the relationship between categorical variables. Results. There was no statistically significant difference in the prevalence of DN between genders (p = 0.633 and r = 0.025). There was a statistically significant relationship between the value of HbA1c and DN, with p = 0.010 and r = 0.136. There is a relationship between age and complaints of neuropathic pain, with p = 0.034 and r = 0.112. The variable, time of disease progression, is also correlated with the appearance of complaints of neuropathic pain with p = 0.020 and r = 0.112. Conclusion. The prevalence of neuropathic pain in subjects with diabetes is not negligible and is associated with modifiable risk factors that can be identified, possibly modified and prevented. The correct approach for these patients, which involves screening and early treatment, is decisive improving functionality and quality of life.
引用
收藏
页码:13 / 19
页数:7
相关论文
共 24 条
[11]   Treatment of painful diabetic neuropathy [J].
Javed, Saad ;
Petropoulos, Ioannis N. ;
Alam, Uazman ;
Malik, Rayaz A. .
THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2015, 6 (01) :15-28
[12]  
Kaur S, 2011, ANN NEUROSCI, V18, P168, DOI [10.5214/ans.0972.7531.1118409, 10.5214/ans.0972-7531.1118409]
[13]   Longitudinal Assessment of Small Fiber Neuropathy Evidence of a Non-Length-Dependent Distal Axonopathy [J].
Khoshnoodi, Mohammad A. ;
Truelove, Shaun ;
Burakgazi, Ahmet ;
Hoke, Ahmet ;
Mammen, Andrew L. ;
Polydefkis, Michael .
JAMA NEUROLOGY, 2016, 73 (06) :684-690
[14]   Symptomatic diabetic and non-diabetic neuropathies in a series of 100 diabetic patients [J].
Lozeron, P ;
Nahum, L ;
Lacroix, C ;
Ropert, A ;
Guglielmi, JM ;
Said, G .
JOURNAL OF NEUROLOGY, 2002, 249 (05) :569-575
[15]   Metabolic Correction in the Management of Diabetic Peripheral Neuropathy: Improving Clinical Results Beyond Symptom Control [J].
Miranda-Massari, Jorge R. ;
Gonzalez, Michael J. ;
Jimenez, Francisco J. ;
Allende-Vigo, Myriam Z. ;
Duconge, Jorge .
CURRENT CLINICAL PHARMACOLOGY, 2011, 6 (04) :260-273
[16]   Neuropathy in prediabetes: does the clock start ticking early? [J].
Papanas, Nikolaos ;
Vinik, Aaron I. ;
Ziegler, Dan .
NATURE REVIEWS ENDOCRINOLOGY, 2011, 7 (11) :682-690
[17]   Diabetic neuropathy: Clinical features, etiology, and therapy [J].
Podwall D. ;
Gooch C. .
Current Neurology and Neuroscience Reports, 2004, 4 (1) :55-61
[18]   Diabetic Neuropathy: A Position Statement by the American Diabetes Association [J].
Pop-Busui, Rodica ;
Boulton, Andrew J. M. ;
Feldman, Eva L. ;
Bril, Vera ;
Freeman, Roy ;
Malik, Rayaz A. ;
Sosenko, Jay M. ;
Ziegler, Dan .
DIABETES CARE, 2017, 40 (01) :136-154
[19]   No Difference in Small or Large Nerve Fiber Function Between Individuals With Normal Glucose Tolerance and Impaired Glucose Tolerance [J].
Pourhamidi, Kaveh ;
Dahlin, Lars B. ;
Englund, Elisabet ;
Rolandsson, Olov .
DIABETES CARE, 2013, 36 (04) :962-964
[20]   Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy [J].
Singleton, JR ;
Smith, AG ;
Bromberg, MB .
DIABETES CARE, 2001, 24 (08) :1448-1453